In metastatic urothelial carcinoma, it has not been established whether circulating tumor DNA (ctDNA) can replace archival primary tissue to assess mutations and biomarkers. Here, the authors show high mutation concordance between ctDNA and tumour tissue, with high consistency in serial samples.
- Gillian Vandekerkhove
- Jean-Michel Lavoie
- Alexander W. Wyatt
